Bharat Biotech Arm Nucelion to Collaborate with Pandorum Tech on Two PRIP-Backed Projects

Bharat Biotech arm Nucelion to collaborate with Pandorum Tech on two PRIP-backed projects

Nucelion Therapeutics and Pandorum Technologies will collaborate on ₹16.97-crore projects to develop investigational therapies for corneal and retinal diseases.

Bharat Biotech’s Nucelion, Pandorum in manufacturing partnership for eye disease therapies

Bharat Biotech’s Nucelion partners with Pandorum to manufacture designer exosome eye therapies for keratopathy and wet AMD, backed by PRIP funding.

Nucelion Therapeutics, Pandorum Technologies to take up 2 ophthalmology projects

Nucelion Therapeutics and Pandorum Technologies join to develop two ophthalmology projects for advanced keratopathy and wet AMD, backed by ₹17 crore.

Nucelion, Pandorum partner on two PRIP-backed ophthalmology projects

The projects will focus on investigational therapies for advanced keratopathy and wet age-related macular degeneration, with a combined planned outlay of ₹16.97 crore

Bharat Biotech Arm Backs New Path to Designer-Exosome Therapies for Eye Disease

Hyderabad, October 28, 2026: As regenerative medicine moves towards more targeted approaches to tissue repair, a partnership between Pandorum Technologies and Bharat Biotech arm Nucelion Therapeutics is focusing on a critical part of the development process: translating designer-exosome research into reproducible manufacturing. The two Indian biotechnology companies have joined forces to advance two investigational ophthalmology […]